NGS: changing the game in CFTR analysis

Cystic fibrosis is a complex multisystem disorder primarily affecting the lungs, pancreas, intestines, and sweat glands, and is commonly diagnosed through CFTR mutation analysis. In clinical laboratories, CFTR testing is among the most frequently requested genetic analyses, often relying on costly 'level 1' and 'level 2' testing approaches.

Explore the implementation of next-generation sequencing (NGS) for comprehensive CFTR analysis. Learn how NGS enables rapid, cost-effective sequencing at the whole gene level, offering a powerful alternative to traditional Sanger-based assays.